S.Biomedics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,855	6,085	4,484	1,410	4,066	6,131
Short-Term Investments	2,000	931.4	7,746	8,175	2,346	6,750
Trading Asset Securities	4,281	7,645	11,720	1,073	1,007	-
Cash & Short-Term Investments	11,136	14,661	23,950	10,658	7,419	12,881
Cash Growth	-55.37%	-38.78%	124.71%	43.66%	-42.41%	3.48%
Accounts Receivable	1,921	1,610	1,753	1,922	1,246	388.8
Other Receivables	-	104.48	206.19	198.83	204.02	67.26
Receivables	1,921	1,804	2,050	2,211	1,540	456.07
Inventory	1,953	1,901	2,325	2,369	1,570	763.73
Prepaid Expenses	-	591	404.79	336.37	426	174.46
Other Current Assets	934.71	873.29	542.39	126.94	245.98	66.43
Total Current Assets	15,944	19,831	29,272	15,700	11,201	14,342
Property, Plant & Equipment	19,019	19,004	4,475	4,962	2,765	3,051
Long-Term Investments	1,575	1,000	500	1,533	1,000	0.06
Other Intangible Assets	465.83	327.32	407.86	118.78	153.76	25.44
Long-Term Deferred Tax Assets	452.81	452.81	436.96	358.55	412.76	-
Other Long-Term Assets	33.33	603.5	9,509	9,275	8,825	377.05
Total Assets	37,491	41,219	44,601	31,947	24,358	17,796
Accounts Payable	430.94	376.97	186.75	479.48	416.17	36.31
Accrued Expenses	-	255.26	266.11	294.48	253.98	182.96
Short-Term Debt	5,384	4,294	1,840	3,547	5,807	1,916
Current Portion of Long-Term Debt	359.6	355.94	6,591	338.51	331.66	96.02
Current Portion of Leases	467.77	440.88	911.85	804.99	442.6	492.23
Current Income Taxes Payable	-	217.78	126.69	39.1	13.46	-
Current Unearned Revenue	4.17	4.17	4.17	4.32	4.28	7.53
Other Current Liabilities	1,894	6,375	1,843	2,144	4,562	1,444
Total Current Liabilities	8,541	12,319	11,770	7,652	11,831	4,175
Long-Term Debt	5,940	6,030	4,634	6,480	7,008	3,783
Long-Term Leases	997.91	1,084	182.49	824.86	206.79	520.66
Long-Term Unearned Revenue	2,040	2,041	2,046	2,050	2,054	2,058
Pension & Post-Retirement Benefits	2,278	2,115	2,087	1,653	1,600	1,370
Other Long-Term Liabilities	979.42	902.92	5,570	932.98	622.38	2,058
Total Liabilities	20,777	24,493	26,289	19,593	23,323	13,964
Common Stock	6,193	6,112	5,873	5,669	5,110	5,110
Additional Paid-In Capital	81,950	81,523	76,481	64,803	44,478	44,478
Retained Earnings	-85,312	-82,945	-74,983	-68,269	-57,759	-51,485
Comprehensive Income & Other	5,382	3,987	4,494	4,809	4,393	4,408
Total Common Equity	8,212	8,677	11,865	7,011	-3,779	2,510
Minority Interest	8,502	8,049	6,447	5,343	4,814	1,321
Shareholders' Equity	16,714	16,725	18,311	12,354	1,035	3,832
Total Liabilities & Equity	37,491	41,219	44,601	31,947	24,358	17,796
Total Debt	13,149	12,205	14,160	11,995	13,796	6,808
Net Cash (Debt)	-2,014	2,456	9,790	-1,337	-6,377	6,073
Net Cash Growth	-	-74.91%	-	-	-	-11.29%
Net Cash Per Share	-167.34	206.86	851.08	-122.35	-624.02	598.26
Filing Date Shares Outstanding	12.39	12.22	11.75	11.34	10.22	10.22
Total Common Shares Outstanding	12.39	12.22	11.75	11.34	10.22	10.22
Working Capital	7,403	7,512	17,502	8,048	-629.62	10,167
Book Value Per Share	662.80	709.84	1010.11	618.41	-369.73	245.64
Tangible Book Value	7,747	8,349	11,457	6,892	-3,932	2,485
Tangible Book Value Per Share	625.21	683.06	975.39	607.93	-384.77	243.15
Land	6,597	6,597	453.44	241.82	241.82	117.16
Buildings	4,592	4,592	902.12	558.2	558.2	349.29
Machinery	8,547	7,700	7,007	6,061	4,849	4,552
Construction In Progress	82.65	4,045	24	829.26	441.24	42.5